Never Run Out Of Buyers To Sell To.

We are seeking a healthy future through continuous research and innovation.For medical and healthcare: We have developed CDFR0812-15/50mg, a combination drug for the treatment of premature ejaculation and erectile dysfunction, which has been approved by the KFDA. This is the world’s first combination therapy, offering a new treatment option. As a leader in Orally Disintegrating Film (ODF) manufacturing technology, we have developed innovative formulation technologies that enable convenient administration and rapid efficacy of drugs. This technology provides patients with a better treatment…
Built from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Annual Revenue$100M to $250M
Estimated OwnershipPublicMatching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.